These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 32760274

  • 1. Jieduquyuziyin Prescription Suppresses Inflammatory Activity of MRL/lpr Mice and Their Bone Marrow-Derived Macrophages via Inhibiting Expression of IRAK1-NF-κB Signaling Pathway.
    Ji L, Fan X, Hou X, Fu D, Bao J, Zhuang A, Chen S, Fan Y, Li R.
    Front Pharmacol; 2020; 11():1049. PubMed ID: 32760274
    [Abstract] [Full Text] [Related]

  • 2. Jieduquyuziyin Prescription-Treated Rat Serum Suppresses Activation of Peritoneal Macrophages in MRL/Lpr Lupus Mice by Inhibiting IRAK1 Signaling Pathway.
    Ji L, Hou X, Deng X, Fan X, Zhuang A, Zhang X, Li R.
    Evid Based Complement Alternat Med; 2019; 2019():2357217. PubMed ID: 31781262
    [Abstract] [Full Text] [Related]

  • 3. Paeoniflorin inhibits activation of the IRAK1-NF-κB signaling pathway in peritoneal macrophages from lupus-prone MRL/lpr mice.
    Ji L, Hou X, Liu W, Deng X, Jiang Z, Huang K, Li R.
    Microb Pathog; 2018 Nov; 124():223-229. PubMed ID: 30149133
    [Abstract] [Full Text] [Related]

  • 4. Jieduquyuziyin Prescription alleviates hepatic gluconeogenesis via PI3K/Akt/PGC-1α pathway in glucocorticoid-induced MRL/lpr mice.
    Ji LN, Wu S, Fu DQ, Fang SJ, Xie GQ, Fan YS, Bao J.
    J Ethnopharmacol; 2022 Feb 10; 284():114815. PubMed ID: 34763039
    [Abstract] [Full Text] [Related]

  • 5. Paeoniflorin Inhibits LPS-Induced Activation of Splenic CD4+ T Lymphocytes and Relieves Pathological Symptoms in MRL/lpr Mice by Suppressing IRAK1 Signaling.
    Ji L, Wang S, Wu S, Bao J, Xie G, Zhang Y, Xu L, Lin N, Wang J, Fan Y, Fu D, Dai Q.
    Evid Based Complement Alternat Med; 2022 Feb 10; 2022():5161890. PubMed ID: 36467552
    [Abstract] [Full Text] [Related]

  • 6. Investigating the Mechanisms of Jieduquyuziyin Prescription Improves Lupus Nephritis and Fibrosis via FXR in MRL/lpr Mice.
    Liu J, Ma Q, Sun Q, Luo Q, Wang Y, Wang C, Zhu A, Zhao L, Yin L, Lou J, Dong Y, Qiu P.
    Oxid Med Cell Longev; 2022 Feb 10; 2022():4301033. PubMed ID: 35855861
    [Abstract] [Full Text] [Related]

  • 7. Jieduquyuziyin prescription enhances CD11a and CD70 DNA methylation of CD4+ T cells via miR-29b-sp1/DNMT1 pathway in MRL/lpr mice.
    Huang S, Peng J, Gan Y, Chen L, Zhu Z, Tian F, Ji L, Fan Y, Zhou C, Bao J.
    J Ethnopharmacol; 2023 Dec 05; 317():116776. PubMed ID: 37343653
    [Abstract] [Full Text] [Related]

  • 8. Jieduquyuziyin prescription suppresses IL-17 production and Th17 activity in MRL/lpr mice by inhibiting expression of Ca(2+)/calmodulin-dependent protein kinase-4.
    Shui B, Xia W, Wen C, Ding X.
    J Nat Med; 2015 Jul 05; 69(3):349-57. PubMed ID: 25821132
    [Abstract] [Full Text] [Related]

  • 9. Jieduquyuzishen Prescription Attenuates Renal Fibrosis in MRL/lpr Mice via Inhibiting EMT and TGF-β1/Smad2/3 Pathway.
    Wu S, Ji L, Fan X, Fang S, Bao J, Yuan X, Fan Y, Xie G.
    Evid Based Complement Alternat Med; 2022 Jul 05; 2022():4987323. PubMed ID: 35591863
    [Abstract] [Full Text] [Related]

  • 10. 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice.
    Li X, Liu J, Zhao Y, Xu N, Lv E, Ci C, Li X.
    BMC Nephrol; 2022 Jul 08; 23(1):243. PubMed ID: 35804318
    [Abstract] [Full Text] [Related]

  • 11. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
    Sun W, Yan S, Yang C, Yang J, Wang H, Li C, Zhang L, Zhao L, Zhang J, Cheng M, Li X, Xu D.
    Immunol Invest; 2022 Aug 08; 51(6):1785-1803. PubMed ID: 35332841
    [Abstract] [Full Text] [Related]

  • 12. PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr mice.
    Zhai JX, Zhang ZX, Feng YJ, Ding SS, Wang XH, Zou LW, Ye DQ.
    Mol Biol Rep; 2012 Jun 08; 39(6):6763-71. PubMed ID: 22318546
    [Abstract] [Full Text] [Related]

  • 13. Jieduquyuziyin prescription alleviates lupus development via inhibiting neddylation pathway to promote Bim-induced apoptosis of double negative T cells.
    Li Y, Duan Q, Wang C, Du L, Jiang Z, Li S, Ruan X, Huang L, He Z, Wen C, Zhang Y.
    J Ethnopharmacol; 2025 Jan 30; 337(Pt 2):118884. PubMed ID: 39362327
    [Abstract] [Full Text] [Related]

  • 14. Jieduquyuziyin prescription promotes the efficacy of prednisone via upregulating Nrf2 in MRL/lpr kidneys.
    Du L, Feng Y, Wang C, Shi X, Wen C, He Z, Zhang Y.
    J Ethnopharmacol; 2022 Nov 15; 298():115643. PubMed ID: 36031105
    [Abstract] [Full Text] [Related]

  • 15. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
    Su B, Ye H, You X, Ni H, Chen X, Li L.
    Life Sci; 2018 Sep 01; 208():26-32. PubMed ID: 30146016
    [Abstract] [Full Text] [Related]

  • 16. Regulatory effect of IL-38 on NF-κB pathway in systemic lupus erythematosus.
    Zhang J, Tabush N, Wei C, Luo L.
    Immunobiology; 2023 Mar 01; 228(2):152322. PubMed ID: 36621308
    [Abstract] [Full Text] [Related]

  • 17. MiR-146a relieves kidney injury in mice with systemic lupus erythematosus through regulating NF-κB pathway.
    Fu HX, Fan XP, Li M, Liu MJ, Sun QL.
    Eur Rev Med Pharmacol Sci; 2019 Aug 01; 23(16):7024-7032. PubMed ID: 31486503
    [Abstract] [Full Text] [Related]

  • 18. Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway.
    You Y, Qin Y, Lin X, Yang F, Li J, Sooranna SR, Pinhu L.
    BMC Nephrol; 2015 Aug 27; 16():148. PubMed ID: 26310926
    [Abstract] [Full Text] [Related]

  • 19. Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice.
    Chen K, Deng Y, Shang S, Tang L, Li Q, Bai X, Chen X.
    Biomed Pharmacother; 2022 Sep 27; 153():113433. PubMed ID: 36076550
    [Abstract] [Full Text] [Related]

  • 20. Jieduquyuziyin prescription alleviates SLE complicated by atherosclerosis via promoting cholesterol efflux and suppressing TLR9/MyD88 activation.
    He Y, Tian W, Zhang M, Qiu H, Li H, Shi X, Song S, Wen C, Chen J.
    J Ethnopharmacol; 2023 Jun 12; 309():116283. PubMed ID: 36898449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.